{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:03:04Z","timestamp":1761058984917},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.atherosclerosis.2009.10.015","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T08:08:14Z","timestamp":1255853294000},"page":"515-519","source":"Crossref","is-referenced-by-count":12,"title":["Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy"],"prefix":"10.1016","volume":"209","author":[{"given":"J.","family":"Puzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Irun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gervas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pocovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib1","first-page":"3635","article-title":"Gaucher disease","volume":"vol. 3","author":"Beutler","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1399-0004.1984.tb00799.x","article-title":"Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease","volume":"26","author":"Ginsberg","year":"1984","journal-title":"Clin Genet"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0026-0495(88)90102-3","article-title":"Abnormalities in lipoprotein metabolism in Gaucher type 1 disease","volume":"37","author":"Le","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib4","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(97)09490-7","article-title":"Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypo-alpha-lipoproteinaemia","volume":"351","author":"Pocovi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ajh.21305","article-title":"Life expectancy in Gaucher disease type 1","volume":"83","author":"Weinreb","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/bcmd.2002.0497","article-title":"Low-dose N-butyldeoxynojirimycin (OGT 918) for type I Gaucher disease","volume":"28","author":"Heitner","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","article-title":"An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment","volume":"27","author":"Pastores","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib11","first-page":"703","article-title":"Short-term effect of miglustat in every day clinical use in treatment-na\u00efve or previously treated patients with type 1 Gaucher's disease","volume":"91","author":"Giraldo","year":"2006","journal-title":"Heamatologica"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib12","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1182\/blood-2007-02-075960","article-title":"Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement","volume":"110","author":"Elstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(99)00188-9","article-title":"Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease","volume":"353","author":"Cenarro","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1157\/13047315","article-title":"Effect of enzyme replacement therapy on lipid profile in patients with Gaucher's disease","volume":"120","author":"Alfonso","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.atherosclerosis.2008.08.027","article-title":"Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease","volume":"204","author":"de Fost","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10038-007-0135-4","article-title":"Mutation analysis and genotype\/phenotype relationships of Gaucher disease patients in Spain","volume":"52","author":"Alfonso","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher's disease clinical, laboratory, radiologic and genetic features of 53 patients","volume":"71","author":"Zimram","year":"1992","journal-title":"Medicine (Balt)"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11883-007-0026-3","article-title":"High-density lipoprotein: antioxidant and anti-inflammatory properties","volume":"9","author":"Navab","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrd1658","article-title":"HDL as a target in the treatment of atherosclerotic cardiovascular disease","volume":"4","author":"Linsel-Nitschke","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.2000.02177.x","article-title":"Withdrawal of enzyme replacement therapy in Gaucher disease","volume":"110","author":"Elstein","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib24","first-page":"1108","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"104","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib25","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.CIR.87.4.1135","article-title":"Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels. The Framingham Offspring Study","volume":"87","author":"Jenner","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib26","first-page":"439","article-title":"High-sensitivity C-reactive protein: clinical importance","volume":"29","author":"Bassuk","year":"2004","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib27","doi-asserted-by":"crossref","unstructured":"NACBLMP Committee Members, Myers GL, Christenson RH, Cushman M et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2009; 55:378\u2013384.","DOI":"10.1373\/clinchem.2008.115899"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","article-title":"Function of C-reactive protein","volume":"32","author":"Du Clos","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","article-title":"Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder","volume":"9","author":"Brooks","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.atherosclerosis.2009.10.015_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009008466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009008466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:58:13Z","timestamp":1558594693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009008466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0021915009008466"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.10.015","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}